Status:

UNKNOWN

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Lead Sponsor:

Gustave Roussy, Cancer Campus, Grand Paris

Conditions:

Epithelial Ovarian Carcinoma

Figo Stage IIIC

Eligibility:

FEMALE

18-65 years

Phase:

PHASE2

Brief Summary

Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a t...

Eligibility Criteria

Inclusion

  • epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy
  • \-

Exclusion

  • Patients ASA 3 patients with no residual tumor at first operation negative microscopic second look

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

67 Patients enrolled

Trial Details

Trial ID

NCT00349505

Start Date

September 1 2004

Last Update

October 6 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut Gustave Roussy

Villejuif, France, 94800

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma | DecenTrialz